These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 36560406)
21. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection. Li M; Guo J; Lu S; Zhou R; Shi H; Shi X; Cheng L; Liang Q; Liu H; Wang P; Wang N; Wang Y; Fu L; Xing M; Wang R; Ju B; Liu L; Lau SY; Jia W; Tong X; Yuan L; Guo Y; Qi H; Zhang Q; Huang Z; Chen H; Zhang Z; Chen Z; Peng X; Zhou D; Zhang L Front Immunol; 2021; 12():697074. PubMed ID: 34262569 [TBL] [Abstract][Full Text] [Related]
22. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters. Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851 [TBL] [Abstract][Full Text] [Related]
23. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Woo PC; Lau SK; Tsoi HW; Chen ZW; Wong BH; Zhang L; Chan JK; Wong LP; He W; Ma C; Chan KH; Ho DD; Yuen KY Vaccine; 2005 Oct; 23(42):4959-68. PubMed ID: 15993989 [TBL] [Abstract][Full Text] [Related]
28. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. Roberts A; Vogel L; Guarner J; Hayes N; Murphy B; Zaki S; Subbarao K J Virol; 2005 Jan; 79(1):503-11. PubMed ID: 15596843 [TBL] [Abstract][Full Text] [Related]
29. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters. Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068 [TBL] [Abstract][Full Text] [Related]
30. Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19). Chan JF; Yuan S; Zhang AJ; Poon VK; Chan CC; Lee AC; Fan Z; Li C; Liang R; Cao J; Tang K; Luo C; Cheng VC; Cai JP; Chu H; Chan KH; To KK; Sridhar S; Yuen KY Clin Infect Dis; 2020 Nov; 71(16):2139-2149. PubMed ID: 32472679 [TBL] [Abstract][Full Text] [Related]
31. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Imai M; Iwatsuki-Horimoto K; Hatta M; Loeber S; Halfmann PJ; Nakajima N; Watanabe T; Ujie M; Takahashi K; Ito M; Yamada S; Fan S; Chiba S; Kuroda M; Guan L; Takada K; Armbrust T; Balogh A; Furusawa Y; Okuda M; Ueki H; Yasuhara A; Sakai-Tagawa Y; Lopes TJS; Kiso M; Yamayoshi S; Kinoshita N; Ohmagari N; Hattori SI; Takeda M; Mitsuya H; Krammer F; Suzuki T; Kawaoka Y Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16587-16595. PubMed ID: 32571934 [TBL] [Abstract][Full Text] [Related]
32. A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters. Lamirande EW; DeDiego ML; Roberts A; Jackson JP; Alvarez E; Sheahan T; Shieh WJ; Zaki SR; Baric R; Enjuanes L; Subbarao K J Virol; 2008 Aug; 82(15):7721-4. PubMed ID: 18463152 [TBL] [Abstract][Full Text] [Related]
33. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters. Roberts A; Thomas WD; Guarner J; Lamirande EW; Babcock GJ; Greenough TC; Vogel L; Hayes N; Sullivan JL; Zaki S; Subbarao K; Ambrosino DM J Infect Dis; 2006 Mar; 193(5):685-92. PubMed ID: 16453264 [TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model. Mohandas S; Yadav PD; Shete-Aich A; Abraham P; Vadrevu KM; Sapkal G; Mote C; Nyayanit D; Gupta N; Srinivas VK; Kadam M; Kumar A; Majumdar T; Jain R; Deshpande G; Patil S; Sarkale P; Patil D; Ella R; Prasad SD; Sharma S; Ella KM; Panda S; Bhargava B iScience; 2021 Feb; 24(2):102054. PubMed ID: 33521604 [TBL] [Abstract][Full Text] [Related]
35. Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein. Chung NH; Chen YC; Yang SJ; Lin YC; Dou HY; Hui-Ching Wang L; Liao CL; Chow YH Vaccine; 2022 Jan; 40(4):574-586. PubMed ID: 34952759 [TBL] [Abstract][Full Text] [Related]
36. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Cavanagh D Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007 [TBL] [Abstract][Full Text] [Related]
37. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model. O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415 [TBL] [Abstract][Full Text] [Related]
40. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Sia SF; Yan LM; Chin AWH; Fung K; Choy KT; Wong AYL; Kaewpreedee P; Perera RAPM; Poon LLM; Nicholls JM; Peiris M; Yen HL Nature; 2020 Jul; 583(7818):834-838. PubMed ID: 32408338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]